The P2X7 receptor is an extracellular ATP-gated cation channel critical in inflammation and immunity, and can be up-regulated by IFN-γ and LPS. This study aimed to examine the effect of TGF-β1 on the up-regulation of P2X7 function and expression in leukemic THP-1 monocytes differentiated with IFN-γ and LPS. Cellsurface molecules including P2X7 were examined by immunofluorescence staining. Total P2X7 protein and mRNA was assessed by immunoblotting and RT-PCR respectively. P2X7 function was evaluated by ATPinduced cation dye uptake measurements. Cell-surface P2X7 was present on THP-1 cells differentiated for 3 days with IFN-γ and LPS but not on undifferentiated THP-1 cells. ATP induced ethidium + uptake into differentiated but not undifferentiated THP-1 cells, and the P2X7 antagonist, KN-62, impaired ATP-induced ethidium + uptake. Co-incubation of cells with TGF-β1 plus IFN-γ and LPS prevented the up-regulation of P2X7 expression and ATP-induced ethidium + uptake in a concentration-dependent fashion with a maximum effect at 5 ng/ml and with an IC 50 of~0.4 ng/ml. Moreover, ATP-induced YO-PRO-1 2+ uptake and IL-1β release were abrogated in cells co-incubated with TGF-β1. TGF-β1 also abrogated the amount of total P2X7 protein and mRNA induced by IFN-γ and LPS. Finally, TGF-β1 prevented the up-regulation of cell-surface CD86, but not CD14 and MHC class II, by IFN-γ and LPS. These results indicate that TGF-β1 prevents the upregulation of P2X7 function and expression by IFN-γ and LPS in THP-1 monocytes. This suggests that TGF-β1 may limit P2X7-mediated processes in inflammation and immunity.
Introduction
The P2X7 receptor is a trimeric ATP-gated cation channel predominately expressed on lymphoid and myeloid leukocytes [1, 2] . Activation of this receptor causes the flux of Ca 2+ , Na + and K + , as well as the uptake of large organic cations and anions. The permeability pathways for these large molecules are unknown, but it appears that more than one pathway may exist and that these pathways vary between cell types [3, 4] . P2X7 activation can induce a variety of downstream events including activation of the NALP3 inflammasome, and the subsequent maturation and release of interleukin (IL)-1β and IL-18 [5] . Predominately due to this property, P2X7 is considered an important sentinel of immunological danger and infection [6, 7] , and a potential target of next generation adjuvants [8] . P2X7 function varies between different human individuals, which in part, can be explained by numerous polymorphisms that alter receptor expression and/or function [9, 10] . Relative P2X7 expression and function also differs between various leukocyte subtypes [11, 12] , and is up-regulated upon differentiation of monocytes to either macrophages [13] or dendritic cells [14] . Moreover, pro-inflammatory molecules such as interferon-γ, (IFN-γ), tumour necrosis factor-α and lipopolysaccharide (LPS) can up-regulate P2X7 expression and function in monocytes/macrophages [15] [16] [17] . The effects of pro-inflammatory molecules on P2X7 are not restricted to leukocytes, as IFN-γ can also up-regulate P2X7 expression and function in epithelial cells [18] . However the role of other soluble molecules in the modulation of P2X7 expression and function remain unknown.
Following on from the pioneering work of Blanchard [19] and Dubyak [20] [21] [22] and their colleagues, the human leukemic monocytic cell line THP-1 has become a well-established model to study the expression and function of P2X7. THP-1 cells express no to low amounts of P2X7, however the expression of this receptor can be induced following differentiation with IFN-γ and LPS, or to a lesser extent with 12-myristate 13-acetate (PMA) [21] . In addition to cation fluxes [21] , activation of P2X7 in differentiated THP-1 cells results in number of downstream signalling events including: cell lysis [19] ; activation of phospholipase D [20] , mitogen-activated protein kinases [23] and caspase-1 [24] ; nuclear translocation of NF-κB [23] ; dissociation of nonmuscle myosin from the P2X7 complex [25] and subsequent inhibition of phagocytosis [26] ; release of mature IL-1β [27] and IL-18 [28] ; shedding of microvesicles [29] ; and killing of intracellular mycobacteria [30] . THP-1 monocytes have also been widely used to screen a number of potential P2X7 antagonists leading to the development of some highly specific and potent P2X7 antagonists [31, 32] . Finally, this cell line was used to establish the blocking action of the only available human anti-P2X7 monoclonal antibody (mAb) [16] .
Transforming growth factor-β1 (TGF-β1) has pleiotropic effects in a variety of biological processes including inflammation and immunity, where it is involved in homeostasis and tolerance, as well as the initiation and resolution of the immune response [33] . As such TGF-β1 has many regulatory roles in restricting the damage caused by the immune response but without negating the elimination of pathogens [33] . The action of TGF-β1 varies between cell types and their state of differentiation, and the combination of cytokines within the extracellular environment [34] . TGF-β1 can down-modulate the expression and function of several cell-surface receptors including CD1d on dendritic cells [35] , FcεRI on mast cells [36] and Fas on follicular dendritic cells [37] . Whether this important immunomodulatory cytokine affects P2X7 is unknown. Using immunocytochemical and molecular techniques, and fluorescent cation dye uptake measurements, we demonstrate that TGF-β1 abrogates the up-regulation of P2X7 expression and function by IFNγ and LPS in THP-1 cells.
Materials and methods

Reagents
RPMI-1640 medium (containing 10 mM HEPES), LPS (Escherichia coli 055:B5), ATP, ethidium bromide, propidium iodide, trypan blue, nigericin and DMSO were from Sigma (St. Louis, MO). FCS (heat-inactivated before use), gentamycin and GlutaMAX were from Invitrogen (Grand Island, NY). Recombinant human IFN-γ and TGF-β1 were from Roche (Mannheim, Germany), and R&D Systems (Minneapolis, MN), respectively. KN-62 and 7-amino actinomycin D (7AAD) were from Alexis Biochemicals (Lausen, Switzerland). YO-PRO-1 2+ was from Molecular Probes (Invitrogen, Eugene, OR). Protease inhibitor cocktail tablets (complete, Mini, EDTAfree) and phenyl-methyl-sulfonyl-fluoride were from Roche Diagnostics (Pensberg, Germany). SuperSignal® West Pico Chemiluminescent Substrate was from Pierce (Rockford, IL). Other reagent grade chemicals were from Sigma or Amresco (Solon, OH).
Murine anti-human P2X7 mAb (clone L4) [16] and isotype control mAb (clone WMD7) were purified from hybridoma supernatant and conjugated to FITC as previously described [11] . FITC-conjugated murine anti-human CD14 (clone TUK4) and isotype control mAb were from Dako (Glostrup, Denmark). PE-conjugated murine anti-human CD39 mAb (clone TU66), FITC-conjugated murine anti-human CD86 (clone 2331) and MHC class II (HLA-DR; clone L243) mAb were from BD (San Jose, CA). FITC-and PE-conjugated isotype control mAb were from eBioscience (San Diego, CA) and BD, respectively. Rabbit anti-rat P2X7 (C-termini epitope) polyclonal antibody (Ab) and blocking peptide were from Alomone Labs (Jerusalem, Israel). Rabbit anti-actin Ab was from Sigma. Peroxidaseconjugated goat anti-rabbit IgG Ab was from Rockland (Gilbertsville, PA).
Cell culture
The human monocytic leukemic cell line, THP-1, was maintained in RPMI-1640 medium supplemented with 10% FCS, 5 μg/ml gentamycin and 2 mM GlutaMAX (complete media) at 37°C/5% CO 2 . THP-1 cells were differentiated as described [21] . Briefly, cells were plated at 1 × 10 6 cells/ml and cultured for 3 days in 5 ml fresh complete media containing 1000 U/ml IFN-γ and 1 μg/ml LPS. TGF-β1 was added as indicated. Untreated THP-1 cells were plated at 3 × 10 5 cells/ml and cultured as above.
Cell-surface receptor measurements
THP-1 cells (5× 10 5 ) were pre-incubated in 100 μl NaCl medium (145 mM NaCl, 5 mM KCl, 5 mM D-glucose, 0.1% BSA, 10 mM HEPES, pH 7.5) containing 10% human AB + serum and 0.01% NaN 3 for 10 min, then incubated with fluorochrome-conjugated mAb and 7AAD (to exclude dead cells) for 20 min, washed and the mean channel fluorescence intensity (MFI) determined using a FACSCalibur or LSR II flow cytometer (BD) and Cell Quest software (BD) or FlowJo software (Tree Star, Ashland, OR) respectively.
Ethidium + and propidium 2+ uptake measurements
Ethidium + or propidium 2+ uptake into THP-1 cells suspended in KCl medium (150 mM KCl, 5 mM D-glucose, 0.1% BSA, 10 mM HEPES, pH 7.5), as used extensively by our group for over 17 years to assess P2X7 pore formation and to avoid the inhibitory effect of Na + on dye uptake, was measured by time-resolved flow cytometry as described [38] . Briefly, THP-1 cells (1 × 10 6 ) were incubated in 1 ml of KCl medium at 37°C. Ethidium + or propidium 2+ (both 25 μM) was added, followed 40 s later by ATP (1 mM). In some experiments, cells were pre-incubated with KN-62 or DMSO (diluent control) for 5 min. The linear mean channel of fluorescent cation dye intensity was measured at 5-s intervals using a FACSCalibur flow cytometer and WinMDI 2.8 software (http://www.scripps.edu). Ethidium + or propidium 2+ uptake (P2X7 function) was quantified as the difference in arbitrary units of area under the fluorescent cation dye uptake curves in the presence and absence of ATP during the first 5 min of incubation.
YO-PRO-1 2+ uptake measurements
YO-PRO-1 2+ uptake into THP-1 cells suspended in NaCl medium was measured by a fixed-time flow cytometric assay as described [39] . Briefly, THP-1 cells (1 × 10 6 ) in 1 ml of NaCl medium containing 1 μM YO-PRO-1 2+ were incubated in the absence or presence of 1 mM ATP for 15 min at 37°C. Incubations were stopped by addition of an equal volume of ice-cold NaCl medium containing 20 mM MgCl 2 and centrifugation. Cells were washed once with NaCl medium. YO-PRO-1 2+ uptake (expressed as MFI) was measured using a LSR II flow cytometer and FlowJo software.
IL-1β release measurements
ATP-and nigericin-induced IL-1β release from THP-1 cells was measured using a modification of a protocol used previously for human monocytes [40] . THP-1 cells were suspended at 5 × 10 5 viable (trypan blue exclusion) cells/ml in RPMI-1640 medium containing 0.1% BSA (pH 7.5) and plated into 24-well plates (0.5 ml/well). Cells were incubated in the absence or presence of 3 mM ATP or 20 μM nigericin for 15 min at 37°C/5% CO 2 . The samples were then centrifuged at 11,000g for 10 s and the cell-free supernatants stored at −20°C for less than 2 weeks before assaying. Amounts of IL-1β were measured using a human IL-1β ELISA (eBioscience) according to the manufacturer's instructions.
P2X7 expression by immunoblotting
THP-1 cells were washed three times in ice-cold PBS and then lysed (1 × 10 7 cells/ml) in ice-cold 50 mM BisTris (pH 7.0) containing 750 mM 6-aminohexanoic acid, 1% n-dodecyl β-D-maltoside, 1 mM phenyl-methyl-sulfonyl-fluoride and a protease inhibitor cocktail (used according to the manufacturer's instructions) over 60 min, sheared 10 times through a 21 G needle and centrifuged (16,000g for 10 min at 4°C). Protein concentrations of cell supernatants were determined using the CB-X TM Protein Assay (G-Biosciences, St Louis, MO) according to the manufacturer's instructions. Cell supernatants (8 μg/lane) were then separated under reducing conditions (5% 2mercaptoethanol) using 4-20% gradient iGels (NuSep, Austell, GA) and transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA). Immunoblotting was performed as described [41] using anti-P2X7 or anti-actin Ab followed by peroxidase-conjugated anti-rabbit Ig antibody, and with Ab binding visualized using chemiluminescent substrate and Amersham Hyperfilm ECL (GE Healthcare, Little Chalfont, Buckinghamshire, UK).
P2X7 expression by RT-PCR
Total RNA was isolated from cells using the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Previously described primers to P2X7 (forward primer 5'-GGATGGTGAAC-CAGCAGCTA-3'; reverse primer 5'-AAGCCACTGTACTGCCCTTC-3') [42] and β-actin (forward 5'-TGGTGGGCATGGGTCAGAAG-3'; reverse 5'-GTCCCGGCCAGCCAGGTCCAG-3') [43] were obtained from Sigma-Genosys (Castle Hill, Australia). PCR amplification was performed using Superscript TM III One-Step RT-PCR System Platinum Taq DNA polymerase (Invitrogen) and corresponding primers for 30 cycles (95°C, 15 s; 50°C, 30 s; 72°C, 60 s) for P2X7 and 30 cycles (95°C, 15 s; 61°C, 30 s; 72°C, 60 s) for β-actin. PCR products were separated on a 2% agarose gel and visualized using ethidium bromide staining.
Statistical analysis
Data is presented as the mean ± SD. Differences between treatments were compared using either the unpaired Student's t-test for single comparisons to control samples or ANOVA for multiple comparisons (using Tukey's post test) using Prism 5 for Mac OS X Version 5.0a (GraphPad Software, San Diego, CA) with P b 0.05 considered significant.
Results
IFN-γ and LPS up-regulate P2X7 expression and function
Differentiation of THP-1 cells with IFN-γ and LPS over 3 days upregulates P2X7 expression and function [21, 22] . Therefore, to confirm these results, THP-1 cells were incubated in the absence or presence of IFN-γ and LPS as previously described [21] , and the amount of cellsurface P2X7 and ATP-induced ethidium + uptake (P2X7 function) measured by flow cytometry. Undifferentiated cells expressed low to negligible amounts of cell-surface P2X7, whereas cell-surface P2X7 was significantly higher on THP-1 cells following differentiation with IFN-γ and LPS (MFI of 0.9 ± 0.8 and 28.7 ± 13.2 respectively, P b 0.01; Fig. 1 ). This difference in the amount of cell-surface P2X7 corresponded with differences in ATP-induced ethidium + uptake. ATP induced negligible amounts of ethidium + uptake into undifferentiated THP-1 cells, but induced significant ethidium + uptake into differentiated cells (mean arbitrary units of ethidium + uptake of 28 ± 79 and 9456 ± 5087 respectively, P b 0.01; Fig. 2 ).
The P2X7 antagonist KN-62 impairs ATP-induced ethidium + uptake
To confirm that the ATP-induced ethidium + uptake into differentiated THP-1 cells was mediated by P2X7, cells were pre-incubated in the presence of the P2X7 antagonist KN-62 [44] or DMSO, and the ATP-induced ethidium + uptake measured. Pre-incubation with 1 μM KN-62 inhibited the ATP-induced ethidium + uptake by 95.1 ± 2.3% ( Fig. 3 ). Basal ethidium + uptake in presence of either KN-62 or DMSO was similar results not shown.
ATP induces ethidium + but not propidium 2+ uptake
The size exclusion cut-off for P2X7 permeants varies between different cell types [4] . To partly define the permeability pathway following P2X7 activation in differentiated THP-1 cells, the ability of ATP to induce propidium 2+ uptake was compared to ethidium + uptake. As above, ATP induced ethidium + uptake into differentiated THP-1 cells (mean arbitrary units of ethidium + uptake of 7128 ± 2492; Fig. 4 ). In contrast, propidium 2+ uptake in the presence of ATP was negligible (mean arbitrary units of propidium 2+ uptake of 31 ± 54; Fig. 4 ).
TGF-β1 prevents the up-regulation of P2X7 by IFN-γ and LPS
Next, the effect of TGF-β1 on the up-regulation of P2X7 function was assessed. THP-1 cells were incubated for 3 days with both IFN-γ and LPS in the presence or absence of increasing concentrations of TGF-β1, and the cell-surface P2X7 expression and the ability of ATP to induce ethidium + uptake measured. Cell-surface P2X7 expression on differentiated THP-1 was abrogated in a concentration-dependent fashion by TGF-β1 with a maximal inhibitory effect observed at 5 ng/ml (69.5± 7.3% inhibition) and with an IC 50 of 0.46±0.25 ng/ml (Fig. 5A ). This inhibitory effect of TGF-β1 on cell-surface P2X7 expression corresponded with decreased amounts in ATP-induced ethidium + uptake, with a maximal inhibitory effect observed at 5 ng/ml (71.7± 10.6% inhibition) and with an IC 50 of 0.37±0.25 ng/ml ( Fig. 5B ).
Next, we examined if delayed addition of TGF-β1 could prevent the up-regulation of P2X7 expression and function by IFN-γ and LPS. THP-1 cells were incubated in the presence of IFN-γ and LPS for 3 days with 10 ng/ml TGF-β1 added on either days 0, 1 or 2. As above, cellsurface P2X7 expression was significantly lower in THP-1 cells incubated with TGF-β1 for 3 days compared to cells incubated in the absence of TGF-β1 ( Fig. 6A ). Cell-surface P2X7 expression on THP-1 cells incubated with TGF-β1 for the final 2 days was lower, albeit not significantly, compared to cells incubated in the absence of TGF-β1 ( Fig. 6A ). Addition of TGF-β1 on the last day of incubation had no significant effect on cell-surface P2X7 expression with values similar to those of cells incubated in the absence of TGF-β1 ( Fig. 6A ). A similar pattern was observed regarding P2X7 function. As above, ATPinduced ethidium + uptake was significantly lower in THP-1 cells incubated with TGF-β1 for 3 days compared to cells incubated in the absence of TGF-β1 ( Fig. 6B ). ATP induced ethidium + uptake into THP-1 cells incubated with TGF-β1 for the final 2 days was also significantly lower compared to cells incubated in the absence of TGF-β1, but to a lesser extent than 3 days incubation with TGF-β1 (Fig. 6B ). The addition of TGF-β1 on the last day of incubation had no significant effect on ATP induced ethidium + uptake with values similar to those of cells incubated in the absence of TGF-β1 ( Fig. 6B) .
To demonstrate that that effect of TGF-β1 on P2X7 function was not limited to ethidium + uptake or to cells suspended in depolarising KCl medium, we first examined ATP-induced YO-PRO-1 2+ uptake in THP-1 cells suspended in NaCl medium as described [39] . ATP induced significant YO-PRO-1 2+ uptake into THP-1 cells differentiated with IFN-γ and LPS, but not undifferentiated cells (Fig. 7A) . The presence of TGF-β1 during the incubation of THP-1 cells with IFN-γ and LPS significantly decreased YO-PRO-1 2+ uptake by 53 ± 1% (Fig. 7A ). Next, we examined ATP-induced IL-1β release from THP-1 cells as described [40] . Nigericin, which induces IL-1β release independently of P2X7 activation, was used as a positive control. ATP induced a small but significant release of IL-1β from THP-1 cells differentiated with IFN-γ and LPS, but not from undifferentiated cells (Fig. 7B) . The presence of TGF-β1 during the incubation of THP-1 cells with IFN-γ and LPS decreased IL-1β release by 79 ± 26%, although this failed to reach statistical significance (Fig. 7B ). This decrease in ATP-induced IL-1β release was not due to differences in IL-1β synthesis or release mechanisms between the two groups as nigericin caused a similar IL-1β release from differentiated cells incubated in the absence or presence of TGF-β1 ( Fig. 7B ).
TGF-β1 prevents the up-regulation of total P2X7 by IFN-γ and LPS
Human monocytes contain a large pool of intracellular P2X7 [11] , which traffics to the cell surface during differentiation to macrophages [17] . Therefore, to determine if the effect of TGF-β1 in differentiated THP-1 cells is due to altered P2X7 trafficking or to a decrease in total P2X7 protein, whole lysates of THP-1 cells were prepared and the amount of P2X7 examined by immunoblotting. Actin was included as a loading control. Immunoblotting with an anti-P2X7 polyclonal Ab failed to detect any bands in untreated THP-1 cells despite the presence of actin (Fig. 8A) , although a faint band at 75 kDa, the predicted size of P2X7, was observed in one of the three experiments performed (results not shown). In contrast, this procedure revealed the presence of a major band at 75 kDa in IFN-γ and LPS-treated THP-1 cells incubated in the presence or absence of TGF-β1 (Fig. 8A) . A minor band at 55 kDa was also detected in these cells in two of the three experiments performed. Of note, the intensity of the 75 and 55 kDa bands were consistently reduced in the IFN-γ and LPStreated THP-1 cells incubated in the presence of TGF-β1 compared to IFN-γ and LPS-treated cells incubated in the absence of TGF-β1, despite the presence of equal amounts of actin (Fig. 8A) . Pre- incubation of the anti-P2X7 polyclonal Ab with blocking peptide abolished immunoreactivity of both the 75 and 55 kDa bands results not shown.
TGF-β1 prevents the up-regulation of P2X7 mRNA by IFN-γ and LPS
Incubation of THP-1 cells with IFN-γ and LPS up-regulates P2X7 mRNA [21] . Therefore, to determine if the effect of TGF-β1 in differentiated THP-1 cells is due to a decrease in P2X7 mRNA, RNA was isolated from THP-1 cells and the amount of P2X7 mRNA examined by RT-PCR. β-actin was included as a house keeping control. P2X7 mRNA was present in undifferentiated THP-1 cells, and incubation with IFN-γ and LPS up-regulated P2X7 mRNA expression ( Fig. 8B) . In contrast, P2X7 mRNA expression in IFN-γ and LPS-treated cells incubated in the presence of TGF-β1 was lower than IFN-γ and LPS-treated cells incubated in the absence of TGF-β1, despite similar expression of β-actin mRNA (Fig. 8B) .
The inhibitory effect TGF-β1 on P2X7 is not due to up-regulation of CD39
The function of purinergic receptors on myeloid leukocytes can be modulated by presence of cell-surface ecto-nucleotidases such as the ecto-ATPDase CD39 [45] . Moreover, P2X7 function is lower in monocyte-derived Langerhans compared to monocyte-derived dendritic cells, which corresponds to differences in CD39 but not P2X7 cell-surface expression [14] . Therefore, the possibility remains that the reduced amount of P2X7 function caused by TGF-β1 in THP-1 cells is partly due to the up-regulation of CD39. Therefore, the expression of cell-surface CD39 was assessed. CD39 however was not detected on either undifferentiated THP-1 cells (MFI of 0.0 ± 0.0; n = 3), or on cells incubated with IFN-γ and LPS in the presence or absence of TGF-β1 (MFI of 0.0 ± 0.0 and 0.0 ± 0.0 respectively; n = 3).
TGF-β1 prevents the up-regulation of CD86 but not CD14 or MHC class II by IFN-γ and LPS
Differentiation of THP-1 cells with IFN-γ and LPS up-regulates CD14 [46] . Therefore, it was determined if the TGF-β1 effect on THP-1 cells incubated with IFN-γ and LPS was specific to P2X7 or could also affect other cell-surface receptors. THP-1 cells incubated with IFN-γ and LPS in the presence or absence of TGF-β1, as well as undifferentiated cells were labelled with a panel of mAb and the expression of cell-surface markers examined by flow cytometry. Undifferentiated THP-1 cells expressed negligible to low levels of cellsurface CD14, CD86 and MHC class II, as well as P2X7 ( Fig. 9 ). Differentiation of THP-1 cells with IFN-γ and LPS increased the cellsurface expression of P2X7, CD14, CD86 and MHC class II ( Fig. 9 ). As above (Figs. 5A and 6A) , the presence of TGF-β1 during the incubation of THP-1 cells with IFN-γ and LPS significantly decreased P2X7 expression ( Fig. 9) . Similarly, TGF-β1 significantly decreased CD86 expression on cells incubated with IFN-γ and LPS (Fig. 9 ). In contrast, CD14 and MHC class II expression was similar on IFN-γ and LPStreated THP-1 cells incubated in the presence or absence of TGF-β1 ( Fig. 9 ).
Discussion
P2X7 expression and function can be up-regulated in the human leukemic monocytic cell line THP-1 upon incubation with IFN-γ and LPS [21, 22] . Using this model of monocyte/macrophage differentiation, we demonstrated that TGF-β1 prevents the up-regulation of P2X7 by IFN-γ and LPS. The effect of TGF-β1 was maximal at 5 ng/ml, where it reduced the up-regulation of P2X7 cell-surface expression and P2X7-induced ethidium + uptake by~70%. The effect of TGF-β1 was concentration-dependent with an IC 50 of~0.40 ng/ml. This inhibitory effect was most prominent when TGF-β1 was present during the entire 3-day incubation with IFN-γ and LPS, however TGF-β1 could partially impair P2X7 up-regulation when added 1 day after the commencement of differentiation with IFN-γ and LPS. The parallel decrease in cell-surface P2X7 expression and P2X7 function in THP-1 cells parallels observations in leukocytes, where P2X7 function correlates with cell-surface P2X7 expression [11, 17] . Finally, this effect of TGF-β1 was not limited to ethidium + uptake, as ATP-induced YO-PRO-1 2+ uptake and IL-1β release was also impaired in differentiated THP-1 cells incubated with TGF-β1 compared to differentiated cells incubated without TGF-β1. Although, it should be noted that the amount of ATP-induced IL-1β released from THP-1 cells incubated for 3 days with IFN-γ and LPS is lower than the amount of ATP-induced IL-1β release from THP-1 cells incubated for 3 h with PMA and then for 6-24 h with LPS [27, 29] or for 2 days with IFN-γ and then for 4 h with LPS [47] . The reason for this difference is unknown, but prolonged (3 days) incubation of THP-1 cells with LPS and/or possibly IFN-γ may result in the loss of IL-1β prior to ATP or nigericin incubation. Alternatively, 3-day incubation of THP-1 cells with IFN-γ and LPS may not induce large amounts IL-1β synthesis.
The mechanism by which TGF-β1 abrogates the up-regulation of cell-surface P2X7 by IFN-γ and LPS in THP-1 cells has been partially elucidated. Immunoblotting of whole cell lysates with anti-P2X7 Ab demonstrated that TGF-β1 prevents the synthesis of the total amount of P2X7 protein in differentiated THP-1 cells. Moreover, this reduction in P2X7 protein paralleled a decrease in P2X7 mRNA expression suggesting that transcription rather than translation is abrogated by TGF-β1 in THP-1 cells incubated with IFN-γ and LPS. However, we cannot exclude the possibility that TGF-β1 may be involved in some post-transcription event such as increased P2X7 mRNA decay, as TGF-β1 can increase the rate of decay of chemokine mRNA induced by LPS in murine macrophages [48] . It appears unlikely that the inhibitory effect of TGF-β1 is due to impaired trafficking of P2X7 as total P2X7 protein amounts were reduced following TGF-β1 treatment, although impaired trafficking cannot be fully excluded as an additional, albeit minor, mechanism. The inhibitory effect of TGF-β1 is not due to increased amounts of a P2X7 variant, which impairs P2X7 expression and function as observed in some epithelial cell lines [49] , as immunoblotting revealed a decrease in both full-length P2X7 (75 kDa) and a shorter P2X7 variant (55 kDa). The reduced P2X7 function following TGF-β1 incubation was also not due to increased levels of the ecto-ATPDase CD39. THP-1 cells, regardless of treatment, failed to express cell-surface CD39, however we cannot exclude the possibility that other ecto-nucleotidases [50] play an ancillary role in the reduced P2X7 function in TGF-β1-treated THP-1 cells. Finally, the inhibitory effect of TGF-β1 is not due to a general block in THP-1 cell differentiation per se as this cytokine failed to impair the upregulation of CD14 and MHC class II.
The THP-1 cell line is a well-established model used to study the P2X7 and its downstream effects (see Introduction). Moreover, THP-1 cells differentiated with IFN-γ and LPS demonstrate characteristics of primary macrophages including plastic adherence [21] , phagocytosis of latex beads [26] and killing of intracellular mycobacteria [30] . Our study confirms the presence of functional P2X7 in THP-1 cells following differentiation with IFN-γ and LPS. Originally, it was observed that incubation of THP-1 cells with IFN-γ and LPS up-regulated ATP-induced cation fluxes [21] , and then subsequently shown that these cation fluxes were impaired by the P2X7 antagonist KN-62 [22] . Similarly, we found that KN-62 impaired ATP-induced ethidium + uptake in differentiated THP-1 cells confirming that the uptake of this organic cation is also mediated by P2X7. Our study also confirms the absence of functional P2X7 in undifferentiated THP-1 cells as observed by others [20, 21] . In contrast another group [23] has demonstrated the presence of functional P2X7 in undifferentiated THP-1 cells whereby the most potent P2X7 agonist, 2'-and 3'-0(4-benzoylbenzoyl) ATP, induced mitogen-activated protein kinase activation, NF-κB translocation and IL-1β release. The reasons for these differences are unknown but may reflect differences in cell lines between laboratories, differences in the relative sensitivities of the different assays, or differences in the relative activation thresholds including amounts of cell-surface P2X7 expression required for different P2X7-mediated events. The detection of P2X7 mRNA and low to negligible amounts of cell-surface P2X7, as well as the detection of P2X7 protein (in one of three experiments) in undifferentiated THP-1 cells in our study suggests these cells may contain low amounts of functional P2X7 but which were undetectable by our cation uptake and IL-1β release assays.
The permeability pathways that mediate the passage of large organic ions following P2X7 activation have not been fully elucidated, although recent data indicates that the dissociation of non-muscle myosin from the P2X7 complex may be involved in P2X7 pore formation [25] . In this study, ATP induced the uptake of ethidium + (314 Da) and YO-PRO-1 2+ (375 Da), but not propidium 2+ (415 Da) into differentiated THP-1 cells. This result is similar to those observed in human lymphocytes [51] and dendritic cells [52] , but contrasts ATP-induced uptake of propidium 2+ uptake in osteoblasts [53] and P2X7-transfected HEK-293 cells [54] . The opening of pannexin-1 has been implicated in the P2X7-mediated uptake of ethidium + in macrophages and P2X7-transfected HEK-293 cells [55] , but the presence of pannexin-1 in THP-1 cells and whether this hemichannel is permeable to propidium 2+ is unknown. Nevertheless our data suggests that propidium 2+ may enter via a different permeability pathway to that of ethidium + , or that the pore size of the P2X7 permeability pathway may differ between cell types.
In addition to P2X7, IFN-γ and LPS up-regulated the expression of CD14, CD86 and MHC class II in THP-1 cells. Although various inflammatory stimuli can up-regulate each of these receptors in THP-1 cells [46, 56, 57] , in relation to incubation with both IFN-γ and LPS this has only been previously demonstrated for CD14 [46] . Thus, our study demonstrates that in addition to CD14, incubation with both IFN-γ and LPS, can also up-regulate CD86 and MHC class II in THP-1 cells. It should be noted however, that in two of the five experiments the up-regulation of MHC class II was negligible despite up-regulation of P2X7, CD14 and CD86. Sub-analysis of the three remaining experiments showed that incubation with IFN-γ and LPS significantly up-regulated MHC class II in THP-1 cells, and that co-incubation with TGF-β1 did not abrogate expression of this cell-surface molecule (results not shown). The null effect of TGF-β1 on CD14 and MHC class II in THP-1 monocytes in the presence of both IFN-γ and LPS contrasts that observed with macrophages treated with either IFN-γ or LPS alone, where TGF-β1 inhibits the expression of either CD14 or MHC class II on IFN-γ-or LPS-treated macrophages respectively [58, 59] . The reasons for these differing results are unknown. The action of TGF-β1 however varies depending on the combination of cytokines within the extracellular environment [34] , thus providing a possible explanation for the differences observed between the various studies, apart from differences in cell type.
The inhibitory effect of TGF-β1 on P2X7 in IFN-γ and LPS-treated THP-1 cells suggests that TGF-β1 may impair the expression and function of P2X7 on macrophages during inflammatory and immune responses. P2X7 activation can stimulate the NALP3 inflammasome to cause the subsequent release of IL-1β from macrophages [5] . Thus, TGF-β1 released during or after infection may serve to reduce ATP-induced IL-1β release by down-regulating P2X7 in macrophages to limit tissue injury or to help resolve the immune response. In contrast, the absence of TGF-β1 may allow maximal P2X7 expression and function to promote ATP-induced IL-1β release during the immune response. Our findings also suggest that aberrant TGF-β1 production may contribute to immune-related disorders in which P2X7 is involved. For example, the absence of TGF-β1 may help to maintain ATP-induced IL-1β release in rheumatoid arthritis where a role for P2X7 has been established [60] . Alternatively, increased TGF-β1 release during infection may downmodulate P2X7 expression in macrophages resulting in impaired ATPinduced killing of intracellular pathogens. In this regard, loss of P2X7 function, resulting from polymorphic variations in the P2RX7 gene, results in impaired ATP-induced killing of intracellular Mycobacterium tuberculosis and Toxoplasma gondi, and increased susceptibility to tuberculosis and toxoplasmosis respectively [61, 62] highlighting the requirement for optimal P2X7 expression and function to control these pathogens. Moreover, both these pathogens can induce TGF-β1 release to suppress macrophage activation to allow their survival and to promote disease [33] , suggesting that down-regulation of P2X7 by this cytokine during infection may provide an additional mechanism by which these pathogens can evade destruction.
In conclusion, this study indicates that TGF-β1 can prevent the upregulation of P2X7 expression and function by IFN-γ and LPS in THP-1 monocytes, and suggest that TGF-β1 may limit P2X7-mediated processes during inflammatory and immune responses. It will be of future importance to determine if TGF-β1 can prevent the upregulation of P2X7 on macrophages differentiated from primary monocytes, as well as the effect of TGF-β1 on P2X7 in other cell types.
